BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03565406-completion@plaintrial.com
DTSTAMP:20261029T163956Z
DTSTART;VALUE=DATE:20200113
SUMMARY:A Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Co
 mbination With Ipilimumab and Nivolumab in Patients With Unresectable Stag
 e III or Stage IV Melanoma — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03565406
URL:https://plaintrial.com/trial/NCT03565406
END:VEVENT
END:VCALENDAR